A new peptide has entered the chat, GUB-UCN2 which is designed with body decomposition in mind. One pin weekly designed to strip fat and GAIN muscle. Created by Gubra. If this goes through Eli Lilly may be in trouble. Here’s what the study entails: Obese rats treated for 12 weeks: > GUB-UCN2 alone: (+14% whole body lean mass) > Fat mass: (-22% low dose / -33% medium dose) > Semaglutide alone: (-3% lean mass / -20% fat mass) > GUB-UCN2 + Semaglutide: (+8% lean mass) > Fat mass with the combo: (-48% to −55%) > Soleus weight: (+25-29%) > Soleus volume: (+29%) > Muscle fiber cross sectional area: (+21-24%) > Intramuscular lipid: (-41-57%) Is Retatrutide about to be a thing of the past?!(CryptoDaddi)